Triple Threat: Triple Pathogen Endocarditis.
Gonzalez JM, Lowenhaar G, Ramgopal M, Chalasani P.
Cureus. 2023 Oct 28;15(10):e47860. doi: 10.7759/cureus.47860. eCollection 2023 Oct.
Triple antiviral therapy in hepatitis C virus infection with or without mixed cryoglobulinaemia: a prospective, controlled pilot study.
Gragnani L, Fabbrizzi A, Triboli E, Urraro T, Boldrini B, Fognani E, Piluso A, Caini P, Ranieri J, Monti M, Laffi G, Zignego AL.
Dig Liver Dis. 2014 Sep;46(9):833-7. doi: 10.1016/j.dld.2014.05.017. Epub 2014 Jun 19.
Management of side-effects.
Rosa I.
Clin Res Hepatol Gastroenterol. 2011 Dec;35 Suppl 2:S69-74. doi: 10.1016/S2210-7401(11)70011-0.
[Treatment guidelines for patients with genotype 1 chronic hepatitis C infection].
Vince A, Duvnjak M, Kurelac I.
Acta Med Croatica. 2013 Oct;67(4):329-38.
Telaprevir or boceprevir triple therapy in patients with chronic hepatitis C and varying severity of cirrhosis.
Saxena V, Manos MM, Yee HS, Catalli L, Wayne E, Murphy RC, Shvachko VA, Pauly MP, Chua J, Monto A, Terrault NA.
Aliment Pharmacol Ther. 2014 May;39(10):1213-24. doi: 10.1111/apt.12718. Epub 2014 Mar 24.
Chronic hepatitis C genotype 1 virus: who should wait for treatment?
Tovo CV, de Mattos AA, de Almeida PR.
World J Gastroenterol. 2014 Mar 21;20(11):2867-75. doi: 10.3748/wjg.v20.i11.2867.
Hydroxychloroquine augments early virological response to pegylated interferon plus ribavirin in genotype-4 chronic hepatitis C patients.
Helal GK, Gad MA, Abd-Ellah MF, Eid MS.
J Med Virol. 2016 Dec;88(12):2170-2178. doi: 10.1002/jmv.24575. Epub 2016 May 25.
Oral diseases associated with hepatitis C virus infection. Part 1. sialadenitis and salivary glands lymphoma.
Carrozzo M.
Oral Dis. 2008 Mar;14(2):123-30. doi: 10.1111/j.1601-0825.2007.01436.x. Epub 2008 Jan 16.
Management of HCV patients with cirrhosis with direct acting antivirals.
Boccaccio V, Bruno S.
Liver Int. 2014 Feb;34 Suppl 1:38-45. doi: 10.1111/liv.12391.
Safety aspects of protease inhibitors for chronic hepatitis C: adverse events and drug-to-drug interactions.
Teixeira R, Nascimento Yde A, Crespo D.
Braz J Infect Dis. 2013 Mar-Apr;17(2):194-204. doi: 10.1016/j.bjid.2012.10.010. Epub 2013 Mar 9.
